Redcliffe Labs India redefine diagnostic: from glucose to genetics testing

Since its inception in 2018, Redcliffe Labs India has endeavoured to be a disrupter in India’s medical lab diagnostics ecosystem. In this talk at RED 2022, founder and managing director Dheeraj Jain discusses some of the company’s key strategic initiatives, such as the use of temperature controlled transport bags and an AI/ML supported infrastructure with a complete ‘Glucose to Genetics’ approach.